(2022). Aortic Valve Endocarditis Post Ventricular Septal Defect Device Closure. test, 6(2), -. doi: 10.21608/cvrepj.2022.351484
. "Aortic Valve Endocarditis Post Ventricular Septal Defect Device Closure". test, 6, 2, 2022, -. doi: 10.21608/cvrepj.2022.351484
(2022). 'Aortic Valve Endocarditis Post Ventricular Septal Defect Device Closure', test, 6(2), pp. -. doi: 10.21608/cvrepj.2022.351484
Aortic Valve Endocarditis Post Ventricular Septal Defect Device Closure. test, 2022; 6(2): -. doi: 10.21608/cvrepj.2022.351484

Aortic Valve Endocarditis Post Ventricular Septal Defect Device Closure

Cardiovascular Research Prove Journal
Volume 6, Issue 2, December 2022    PDF (70.09 K)
Document Type: Abstracts
DOI: 10.21608/cvrepj.2022.351484
Abstract
ventricular septal defect (VSD) is a common 
congenital heart disease (CHD) in childhood, and 
its incidence is about 20% of CHD . Surgical 
closure or repair is safe with acceptable results. 
Transcatheter VSD closure offers excellent 
results.
Statistics
Article View: 28
PDF Download: 25